News

A research team is the first to reveal that a molecule in the brain – ophthalmic acid – unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function.

A new drug, RI-AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to Alzheimer's disease. Early tests demonstrated the drug's effectiveness in reducing tau aggregation.

A study reveals that geckos utilize the saccule, traditionally linked to balance, for detecting low-frequency vibrations. This discovery suggests that reptiles may have a unique auditory mechanism.

A novel semi-synthetic compound can be derived from natural compounds to produce potent activity against tuberculosis, including multi-drug resistant strains.

Researchers from Monash University have isolated activity from individual neurons within the vagus nerve. Considering the firing activity of these neurons in the context of cardiac and respiratory cycles has aided their function identification.

A study demonstrates that human embryonic stem cell-derived retinal organoid sheets effectively closed macular holes in a monkey model. The transplantation promoted the survival and maturation of retinal tissue.

A more targeted therapy for multiple sclerosis that uses special immune cells from the patients has shown early promise.

Researchers found that an O-methylflavone compound from African wormwood can kill Mycobacterium tuberculosis in both active and dormant states. While preliminary, these findings suggest a promising direction for new tuberculosis therapies.

An array of nanopillars that can breach the nucleus of cells without damaging the membrane could open new possibilities in gene therapy.

A trial found low doses of lithium aspartate ineffective for long COVID-related fatigue and brain fog. However, a supplemental study indicated higher doses might help.